Skip to main content
Clinical Trials/CTRI/2012/12/003249
CTRI/2012/12/003249
Recruiting
Phase 3

Phase III Randomized trial of image guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy for late toxicity reduction after postoperative adjuvant radiotherapy in CA Cervix - PARCER

Tata Memorial Centre0 sites240 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Cervical cancer
Sponsor
Tata Memorial Centre
Enrollment
240
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Age \>18 to 65 years
  • 2\.Histopathological diagnosis of carcinoma cervix with post operative intermediate or high risk feature
  • 3\.Planned for Wertheimâ??s hysterectomy or has already undergone Wertheimâ??s hysterectomy or has undergone simple hysterectomy with no evidence of residual nodes on MRI PET imaging\+/\- confirmatory nodal biopsy
  • 4\.No evidence of para aortic nodal metastasis

Exclusion Criteria

  • 1\.History of multiple previous abdominal surgery placing patient at baseline high risk of bowel toxicity or any other medical condition with baseline bowel movement disorder
  • 2\.Rectal polyps or extensive hemorrhoids

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Radiation therapy with Image Guided Intensity Modulated Radiotherapy and standard radiation therapy after surgery in cervical cancer patients.
CTRI/2010/091/002959il240
Completed
Not Applicable
Phase I/II clinical trial of stereotactic body radiotherapy in patients with cervical cancer who are unsuitable for intracavitary brachytherapyterine cervical cancer
JPRN-UMIN000036845Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital21
Active, not recruiting
Phase 1
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung CancerRecurrent Lung Non-Small Cell CarcinomaStage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7
NCT01629498M.D. Anderson Cancer Center146
Completed
Phase 3
Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca CervixCancer Cervix
NCT01279135Tata Memorial Hospital300
Active, not recruiting
Phase 1
An Imaging Sub-Study of the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium - The Imaging Sub-study for the Fracture TrialPostmenopausal OsteoporosisMedDRA version: 9.1Level: LLTClassification code 10017082Term: Fracture due to osteoporosisMedDRA version: 9.1Level: LLTClassification code 10031285Term: Osteoporosis postmenopausal
EUCTR2008-004578-42-DKMerck & Co. Inc.400